Auxochromofours Solutions Private Limited OECD Toxicology Studies: A Complete Guide to Preclinical Toxicity Testing and Regulatory Compliance Developing a new pharmaceutical product, medical device, chemical, or biotechnology product requires more than proving its effectiveness it also requires demonstrating its safety. Before any product p...
Auxochromofours Solutions Private Limited Genotoxic Impurities in Pharmaceuticals: Identification, Risk Assessment & ICH M7 Compliance In pharmaceutical manufacturing, ensuring drug safety extends far beyond demonstrating therapeutic efficacy. Manufacturers must also identify and control trace impurities that could pose serious healt...
Auxochromofours Solutions Private Limited Global Cosmetic Regulations Driving Safety Assessments The Modernization of Cosmetics Regulation Act (MoCRA) represents the most significant update to U.S. cosmetic regulations in decades. Under MoCRA, the Responsible Person typically the manufacturer, br...
Auxochromofours Solutions Private Limited Medical Device Toxicology: ISO 10993 Compliance, Chemical Characterization & Risk Assessment While pharmaceutical products contain defined active ingredients with established toxicological profiles, medical devices comprise multiple engineering materials that may release trace chemicals durin...
Auxochromofours Solutions Private Limited GAMP 5 Second Edition: What Changed and Why It Matters for Your CSV Programme The GAMP 5 Second Edition, published by ISPE in 2022, is the first major update to the globally accepted Good Automated Manufacturing Practice (GAMP 5) guidance since 2008. Designed to reflect the evo...
Auxochromofours Solutions Private Limited IEC 62304 vs Computer System Validation (CSV): Understanding the Key Differences As pharmaceutical companies, medical device manufacturers, and Contract Research Organizations (CROs) continue to adopt advanced digital technologies, software validation and regulatory compliance hav...
Auxochromofours Solutions Private Limited Computer System Assurance (CSA) vs Traditional CSV: Key Differences, Benefits & Best Practices As pharmaceutical companies continue to modernize their digital infrastructure, validation practices are also evolving. For years, Computer System Validation (CSV) has been the industry standard for d...
Auxochromofours Solutions Private Limited SaaS Validation in Pharmaceutical Companies: A Complete Guide to GxP Compliance The pharmaceutical industry is rapidly embracing cloud-based Software as a Service (SaaS) solutions to streamline operations, improve collaboration, and reduce IT infrastructure costs. Applications su...
Auxochromofours Solutions Private Limited 2D vs 3D Cell Culture Models: Which Is Better? Drug discovery and biomedical research have evolved significantly over the past few decades, with cell culture models playing a central role in understanding disease mechanisms and evaluating new ther...
Auxochromofours Solutions Private Limited How In-Vitro Studies Accelerate Pharmaceutical Development Bringing a new medicine to market is a long and demanding process. Before a drug reaches patients, it must pass through years of research, laboratory testing, preclinical studies, and clinical trials....
Auxochromofours Solutions Private Limited Computer System Validation Trends Every QA Team Should Watch in 2026 The pharmaceutical and life sciences industries are rapidly transforming their approach toward Computer System Validation (CSV). As regulatory expectations continue to evolve alongside digital transfo...
Auxochromofours Solutions Private Limited FDA Study Data Technical Conformance Guide v6.2: Key SEND Updates Sponsors Need to Know in 2026 The latest revision of the FDA Study Data Technical Conformance Guide (sdTCG v6.2) introduces several important changes for sponsors managing SEND submissions. While the update does not completely ove...
